NCT01658111

Brief Summary

Numerous studies showed that ascertaining the effectiveness of rehabilitative interventions on conditions leading to long-term disability, such as stroke, is a complex task because the outcome depends on many interacting factors. Several studies underline the importance of brain plasticity and its therapeutic potential in neurological disorders. Accredited theories of cortical reorganization after brain lesion endorse the use of early, intensive, repetitive, and context-related exercise as optimal strategies to promote motor relearning and minimize motor deficit. The use of robotic systems in upper limb motor rehabilitation programs has been already demonstrated to provide safe and intensive treatment to subjects with motor impairments due to a neurological injury: several studies showed the advantages of robotic therapy on chronic post-stroke patients, even if no consistent influence on functional abilities was found and evidence of better results providing intensive treatments, both robotic and conventional rehabilitative techniques, was found. Recent development and recent trial in robot-assisted rehabilitation has shown the great potential of robotic devices for delivering repetitive training, thus facilitating a high intensity and a large dose of training during sub-acute and chronic phases of stroke rehabilitation. The proposed project, through a randomized controlled observer-blind multicenter trial is aimed at evaluating the effectiveness of robot-assisted therapy as additional treatment to the standard physical therapy in the early phase after stroke onset and evaluating in conjunction with EEG and EMG recordings the effects of the rehabilitative treatments in a quantitative, measurable way, by providing reliable and objective methods for measuring functional recovery after stroke.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jul 2012

Typical duration for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 6, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

October 3, 2022

Status Verified

August 1, 2012

Enrollment Period

1 year

First QC Date

July 24, 2012

Last Update Submit

September 30, 2022

Conditions

Keywords

StrokeRobotsEEGEMG

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline in Fugl-Meyer Scale at 28 weeks.

    at inclusion, week 4 and week 28

  • Change from Baseline in Box and Block Test at 28 weeks.

    at inclusion, week 4 and week 28.

Secondary Outcomes (1)

  • Change from Baseline in Modified Ashworth Scale at 28 weeks.

    at inclusion, week 4 and week 28.

Other Outcomes (1)

  • Change from Baseline in Frenchay Arm Test at 28 weeks.

    at inclusion, week 4 and week 28.

Study Arms (2)

Traditional physiotherapy

ACTIVE COMPARATOR

Each subject will receive 4 weeks of traditional upper limb rehabilitation treatment (20 sessions, 5 days a week for 4 weeks).

Procedure: Traditional physiotherapy

Robot Group

EXPERIMENTAL

Each subject will be asked to perform five sessions per week goal-directed, planar reaching tasks, which emphasizes shoulder and elbow movements, moving from the centre target to each of 8 peripheral targets equally spaced on a 0.14 m radius circumference around a centre target using the InMotion2 (IM2) system (20 sessions- 5 days a week for 4 weeks).

Device: Robot Group

Interventions

The MIT-MANUS/InMotion2 (Interactive Motion Technologies, Inc., Watertown, MA, USA) system has two translational degrees of freedom (dof): shoulder abduction-adduction (ab-ad), elbow flexion-extension (flexext). The robotic system supports the execution of reaching movements in the horizontal plane through an assist as needed control strategy. The robot can guide the movement of the upper limb of the patients and record end-effector physical quantities such as the position, velocity, and applied forces. The device is designed to have a low intrinsic end-point impedance (i.e., be back-drivable to easily carry the weight of the patient's arm, to execute movements without constraint and offer minimal resistance. A 3-dof force transducer is placed at the robots end-effector, as well.

Also known as: MIT-MANUS/InMotion2
Robot Group

Active or passive exercises.

Also known as: FKT
Traditional physiotherapy

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first acute event of cerebrovascular stroke
  • unilateral paresis,
  • ability to understand and follow simple instructions,
  • ability to remain in a sitting posture, even through seat belts for trunk fixation.

You may not qualify if:

  • bilateral impairment,
  • severe sensory deficits in the paretic upper limb,
  • cognitive impairment or behavioral dysfunction that would influence the ability to comprehend or perform the experiment,
  • refusal or inability to provide informed consent
  • other current severe medical problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

IRCCS San Raffaele Roma

Roma, 00161, Italy

Location

Auxilium Viate Volterra

Volterra, Italy

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Michela Goffredo, BME

    IRCCS San Raffaele Rome

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2012

First Posted

August 6, 2012

Study Start

July 1, 2012

Primary Completion

July 1, 2013

Study Completion

August 1, 2014

Last Updated

October 3, 2022

Record last verified: 2012-08

Locations